Skip to main content
. 2018 Oct 8;10:726–736. doi: 10.1016/j.dadm.2018.09.001

Table 2.

Performance of DSI to predict conversion to MCI or any type of dementia in the ADC cohort, for the total cohort and for patients with extreme DSI values

Variable % Stable SCD, n Progressive SCD, n AUC Balanced accuracy Sensitivity Specificity PPV NPV
Demographics 291 63 0.74 ± 0.04 66.0 ± 5.0 66.0 ± 11.7 65.9 ± 6.1 29.7 ± 3.8 90.1 ± 2.8
APOE 267 50 0.60 ± 0.05 59.7 ± 4.9 53.9 ± 8.4 65.5 ± 4.5 22.7 ± 4.4 88.4 ± 2.4
Neuropsychology 290 62 0.69 ± 0.06 62.7 ± 4.4 61.6 ± 10.8 64.3 ± 5.3 26.9 ± 3.3 88.7 ± 2.4
CSF 194 33 0.77 ± 0.07 69.9 ± 5.0 66.1 ± 11.3 73.6 ± 6.5 30.3 ± 5.8 92.8 ± 2.6
MRI (1 T, 1.5 T, 3 T) 277 55 0.68 ± 0.05 61.4 ± 4.3 80.1 ± 10.1 42.8 ± 6.8 21.8 ± 2.5 91.9 ± 3.5
MRI (>1 T) 123 25 0.73 ± 0.09 69.1 ± 7.8 64.9 ± 15.2 73.3 ± 7.6 33.6 ± 9.6 91.3 ± 4.0
Demographics + APOE + Neuropsychology + CSF + MRI (1 T, 1.5 T, 3 T) 291 63 0.80 ± 0.05 74.0 ± 4.2 82.9 ± 8.4 65.1 ± 5.8 34.2 ± 3.8 94.7 ± 2.4
Demographics + APOE + Neuropsychology + CSF + MRI (>1 T) 291 63 0.81 ± 0.06 74.1 ± 5.8 75.7 ± 11.2 72.6 ± 4.8 37.7 ± 5.5 93.3 ± 2.8
DSI < 0.2 or DSI > 0.8
 Demographics + APOE + Neuropsychology + CSF + MRI (1 T, 1.5 T, 3 T) 14 ± 4 12 ± 5 5 ± 2 0.81 ± 0.10 83.3 ± 7.4 98.9 ± 4.2 67.7 ± 13.6 59.0 ± 17.4 99.4 ± 2.3
 Demographics + APOE + Neuropsychology + CSF + MRI (>1 T) 21 ± 6 20 ± 8 5 ± 2 0.83 ± 0.11 84.1 ± 9.6 85.4 ± 17.6 82.8 ± 7.1 56.2 ± 17.1 96.3 ± 4.6
DSI < 0.3 or DSI > 0.7
 Demographics + APOE + Neuropsychology + CSF + MRI (1 T, 1.5 T, 3 T) 37 ± 6 34 ± 7 10 ± 3 0.84 ± 0.06 80.7 ± 6.0 89.6 ± 11.4 71.8 ± 9.4 47.8 ± 10.9 96.8 ± 3.0
 Demographics + APOE + Neuropsychology + CSF + MRI (>1 T) 48 ± 6 47 ± 7 9 ± 3 0.84 ± 0.09 84.1 ± 7.3 84.9 ± 14.2 83.3 ± 5.5 50.8 ± 12.9 97.0 ± 2.6

Abbreviations: AUC, area under the receiver operating characteristic curve; SCD, subjective cognitive decline; PPV, positive predictive value; NPV, negative predictive value; APOE, apolipoprotein E; DSI, Disease State Index.

NOTE. For the extreme DSI values, n: number of patients in a cross-validation fold having the DSI value in the given range; %: percentage of patients in a test set (n = 118) of a cross-validation fold having the DSI value in the given range. Values are presented as mean ± standard deviation over 10 iterations of three-fold cross-validation.